Navigation Links
Enormous growth in use of WHO Fracture Risk Assessment Tool
Date:1/15/2012

FRAX, which is available free online at http://www.shef.ac.uk/FRAX/, is being used by an increasing number of physicians around the world the online version alone is used to calculate 10-year probability of fracture in approximately 2.8 million patients annually, with numbers growing steadily.

The FRAX tool is country-specific and can be used with or without the input of Bone Mineral Density (BMD) values measured at the femoral neck.

Launched on January 13, 2012, version 3.5 of the tool now includes new models for Ecuador, Norway, Russia, Slovakia and Sri Lanka. The model for Sri Lanka is the first surrogate model, built by combining national mortality data with hip fracture data from a representative, surrogate country. Revised epidemiological data have also been incorporated into the models for Belgium, Czech Republic, Italy and Lebanon.

The FRAX tool is now available for the following countries/territories:

  • Asia China, Hong Kong, Taiwan, Japan, Singapore (3 models), Philippines, Sri Lanka (surrogate model), South Korea
  • Europe Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Malta, Poland, Romania, Russia, Slovakia, Spain, Sweden, Switzerland, Turkey and UK
  • Middle East and Africa Jordan, Lebanon, Tunisia
  • North America Canada, USA (4 models)
  • Latin America Argentina, Colombia, Ecuador, Mexico
  • Oceania Australia, New Zealand

Version 3.5 is available in the following 18 languages: English, Arabic, Chinese (traditional and simplified), Czech, Danish, Finnish, French, German, Italian, Korean, Japanese, Polish, Romanian, Russian, Spanish, Swedish, Turkish.

Dr Eugene McCloskey, a co-founder of FRAX and Professor in Adult Bone Disease and Honorary Consultant at the Metabolic Bone Centre, University of Sheffield UK, stated, "The availability of FRAX has really stimulated a great deal of interest in the epidemiology and burden of osteoporosis. Fracture probability continues to be incorporated into an increasing number of clinical guidelines. We welcome the opportunity to work with researchers in many countries to continue to develop the number of available FRAX models."

FRAX now accessible in various formats:

FRAX is more widely accessible than ever before. A stand-alone version of FRAX that operates on a desktop or laptop computer without the need for internet access has been available since September 2011. FRAXDesktop, developed in cooperation with the International Osteoporosis Foundation (IOF) and available by subscription at http://who-frax.org/index.php can be licensed in two different formats. The Individual-Entry version can be used to assess an unlimited number of individual patients in the clinic and the Multi-Patient Entry version is designed for researchers who need to analyse data from large cohorts in a single operation.

FRAX has also been incorporated into several types of densitometers and is available as an application on the i-Phone and i-Pad obtainable at http://itunes.apple.com/us/app/frax/id370146412?mt=8.


'/>"/>
Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Related medicine news :

1. Treatment of rectal cancer varies enormously between different European countries
2. Improving DNA sequencing: Sponge-like biosensor crams enormous power into tiny space
3. Growth in U.S. Health Spending Stayed Slow in 2010
4. Fibroblasts contribute to melanoma tumor growth, say Moffitt Cancer Center researchers
5. Study reveals how normal cells fuel tumor growth
6. Every cloud has a silver lining: Weather forecasting models could predict brain tumor growth
7. Nanometer-scale growth of cone cells tracked in living human eye
8. Team designs a bandage that spurs, guides blood vessel growth
9. Blue light irradiation promotes growth, increases antioxidants in lettuce seedlings
10. University of Leicester study fundamentally alters our understanding of lung growth
11. Stopping dangerous cell regrowth reduces risk of further heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, ... a raffle. Throughout the month of February, patients who visit Hamlin Dental Group will ... a dinner for two at the Cheesecake Factory. , Tickets are available for ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Dr. David Mahon ... Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient Rated Henderson ... is an online directory that recognizes local physicians and dentists who have earned high ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... the pre-eminent publication and community for those in the fight against cancer, has ... important in their success. HRA will release top-line findings in a webinar, ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... her Smiling Patriot program today with a new Indiegogo campaign . ... care to homeless veterans in the Los Angeles area, either as a participating patient ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez has lived his ... to spiritually evolve, which is the purpose of everyone in this universe. As Gutierrez ... (published by Balboa Press) attempts to guide readers to expand one’s spiritual life. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)...  The particle counters market is projected to ... 275.9 million in 2016, at a CAGR of ... http://www.reportlinker.com/p04718602-summary/view-report.html The growing pharmaceutical and ... growth in manufacturing industries in emerging nations are ... counters. On the other hand, technical limitations of ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
Breaking Medicine Technology: